Objective: To observe the effect of acupuncture combined with acupoint application in the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Methods: Sixty-two AECOPD patients were randomly divided into medication (control) group and acupuncture+acupoint application (test) group (n=31 in each group). Patients of the control group were treated with inhalation of Draco Lakemedel AB (Budesonide Powder) for 15-20 min/time, 2 times/d for 15 d, and those of the test group were treated by acupuncture stimulation of Lieque (LU 7), Chize (LU 5), Danzhong (CV 17), Fenglong (ST 40), Zusanli (ST 36), and Taixi (KI 3) and application of medicinal cake[containing Xingren (Amygdalus Communis Vas), Sangbaipi (Morus alba L.), etc.] to bilateral Feishu (BL 13), Tiantu (CV 22), bilateral Shenshu(BL 23) and Pishu (BL 20). The lung function[forced expiratory volume in 1 second (FEV 1)%, forced vital capacity (FVC), and FEV 1/FVC] was detected using a pulmonary detector, the severity scores of symptoms (cough, stethocatharsis, gasp, wheeze, short breath, 0-3 points) and daily life quality[Client's Assessment of Treatment Scale (CAT, 7 items)] were assessed before and after the treatment.
Results: After the treatment, the scores of symptoms, life quality (CAT) were significantly decreased (P<0.05), while FEV 1% and FEV 1/FVC levels were considerably increased (P<0.05) in both groups. The effects of the test group were significantly superior to those of the control group in down-regulating symptom score and life quality score and raising FEV 1% and FEV 1/FVC levels (P<0.05). In addition, of the two 30 cases in the control and test groups, 10 and 18 patients experienced marked improvement, 16 and 10 were effective, 4 and 2 failed in the treatment, with the effective rates being 86.66% and 93.33%, respectively. The effective rate of acupuncture+acupoint application was obviously superior to that of medication (P<0.05).
Conclusions: Acupuncture combined with acupoint application is effective in improving the symptoms, life quality and lung function in patients with AECOPD.